About

Aqua Ventures was founded in 2015. Its core management team consists of professionals with extensive full-cycle investment management experience and a deep entrepreneurial mindset. The management team focus on early-stage venture opportunities in China from angel to Series A rounds, with investment focus on industrial Internet, artificial intelligence, intelligent manufacturing, biotechnology and other sectors. Committed to growing alongside the new generation of China’s most outstanding entrepreneurs, Aqua team supports them in building great enterprises that deliver sustainable value creation, thereby advancing the technological upgrading, modernization and globalization of China’s core industries.

The core limited partners of Aqua funds are all blue-chip investors, including central and local government fund of funds, leading industrial enterprises, and renowned entrepreneurs with deep ties to the fund management team. Aqua and its team have been repeatedly recognized by mainstream Chinese venture capital media, winning honors such as Best Emerging Fund, LP’s Most Favored Early-stage VC Firm, Entrepreneur’s Most Favored Investor, China’s Most Insightful Investor of the Year, and Industrial Investment Institution of the Year for China’s New-quality Productive Forces.

Representative portfolio companies from Qianshi’s past investments include Edan Instruments (300206.SZ), Kingfriend (603707.SH), Career International (300662.SZ), Peijia Medical (09996.HK), Bona Film Group (001330.SZ), Guomai (301052.SZ), Be Friends (01450.HK), Distinct HealthCare (02677.HK), iKang Healthcare Group (NASDAQ: KANG, privatized), Lygo Technology (Qingtuanshe), Huida Technology, MolBreeding Biotechnology, Green Long Biotechnology, CorrectSequence Therapeutics, Dami & Xiaomi, Fordeal, Litmatch, Deeptech, AllBlu, Canbox, etc.and other industry benchmark enterprises.